Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Bill.com | BILL | 17. oct 2024 | 56.67 | +2.07 |
Binah Capital Group | BCG | 17. oct 2024 | 2.44 | -5.43 |
BingEx Limited - American Depositary Shares | FLX | 17. oct 2024 | 14.97 | 0.00 |
BIO-key International | BKYI | 17. oct 2024 | 0.68 | -3.22 |
Bio-Path | BPTH | 17. oct 2024 | 1.07 | -7.76 |
Bio-Rad Laboratories A | BIO | 17. oct 2024 | 343.98 | +4.30 |
Bio-Rad Laboratories B | BIO-B | 17. oct 2024 | 334.85 | 0.00 |
Bio-Techne | TECH | 17. oct 2024 | 70.15 | -2.30 |
BioAffinity Technologies | BIAF | 17. oct 2024 | 2.13 | -2.29 |
BioAtla | BCAB | 17. oct 2024 | 1.85 | -5.61 |
BioCardia | BCDA | 17. oct 2024 | 2.65 | +0.57 |
Bioceres Crop Solutions | BIOX | 17. oct 2024 | 7.38 | +1.65 |
BioCryst Pharmaceuticals | BCRX | 17. oct 2024 | 7.49 | -1.06 |
Biodesix | BDSX | 17. oct 2024 | 1.63 | -1.81 |
Biodexa Pharma ADR | BDRX | 17. oct 2024 | 5.87 | -30.12 |
Biofrontera | BFRI | 17. oct 2024 | 0.75 | -1.17 |
Biogen | BIIB | 17. oct 2024 | 189.55 | +0.29 |
Biohaven | BHVN | 17. oct 2024 | 51.64 | +0.33 |
Biolase | BIOL | 17. oct 2024 | 0.13 | 0.00 |
BioLife Solutions | BLFS | 17. oct 2024 | 23.14 | +0.83 |
BioLineRX ADR | BLRX | 17. oct 2024 | 0.46 | -1.70 |
BioMarin Pharmaceutical | BMRN | 17. oct 2024 | 69.47 | -0.98 |
Biomea Fusion | BMEA | 17. oct 2024 | 11.42 | -0.78 |
Biomerica | BMRA | 17. oct 2024 | 0.34 | -3.14 |
BiomX | PHGE | 17. oct 2024 | 0.95 | -3.02 |
Bionano Genomics | BNGO | 17. oct 2024 | 0.33 | -2.16 |
BioNexus Gene Lab | BGLC | 17. oct 2024 | 0.38 | -2.21 |
Bionomics ADR | BNOX | 17. oct 2024 | 0.27 | +0.67 |
BioNTech ADR | BNTX | 17. oct 2024 | 114.47 | -2.78 |
Biora Therapeutics | BIOR | 17. oct 2024 | 0.55 | -6.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.